RU-486 ABORTION PILL

    On 1998-JUN-24, the U.S. House passed a bill to bar approval of RU-486 by the Food and Drug Administration. The vote was 223 to 202. Tom Coburn (R-OK) said that if the pill were approved, it would be "killing babies". Also, he said that it would violate the FDA's directive of approving drugs that are "safe and effective." The bill was never signed into law.

    Sept. 17, 2005. A California teenager visited a Planned Parenthood clinic. Seven days later, Holly Patterson was dead after taking the abortion drug RU-486.

    She was seven weeks pregnant the latest point in pregnancy for which RU-486 is recommended by the Food and Drug Administration.

    The death of the Livermore, Calif., girl on Sept. 17 is believed to be the third U.S. fatality connected with the drug.

    "She just turned 18," Holly's father, Monty Patterson, told the San Jose Mercury News. "They told her it was safe and it killed her."

    Saturday, March 18, 2006. FDA is investigating two more deaths associated with the abortion pill RU-486. In the wake of the announcement, Planned Parenthood announced it would change the way it administers drug-induced abortions. And abortion opponents are stepping up their calls for the drug to be pulled from the market.

    How it Works:

    RU-486 is to be taken within than 49 days (7 weeks) after the start of the last menstrual period. It is an antiprogestin. It binds itself to progesterone receptors on the wall of the uterus thus blocking the effect of the woman's natural progesterone. This triggers the shedding of the uterine wall, much like a normal period.

    RU-486 also opens the cervix, and causes mild contractions which help expel the embryo. The initial dose often causes some nausea, headache, weakness, diarrhea and/or fatigue. It is sometimes taken at home; other times it is taken at a clinic.

    One or two days later, the woman takes a prostaglandin pill, typically misoprostol (a.k.a. Cytotec). This causes her cervix to soften and dilate. Contractions of her uterus begin. French studies showed that in 54% of the time, the embryo is expelled within 4 hours. In another 22% of cases, it is expelled within 24 hours. She is observed in a clinic for 4 to 6 hours. The medication causes bleeding and deep cramps. Some days later, she returns again for an examination to confirm that the abortion was complete.

    There was general agreement by the year 2000 that the treatment works about 95% of the time. However, after nine months of usage by the Planned Parenthood Federation of America (PPFA), its "success rate" has been found to be in excess of 99%. It is most effective if taken during the first 7 weeks of pregnancy. After 9 weeks, it is less effective and the side-effects are more severe. Bleeding can last up to 9 days (compared with about 5 days for a surgical abortion). Approximately 1% of women will have heavy bleeding which requires additional treatment. The medication totally fails to cause an abortion in about 1% of the women; about 2 to 3% of women experience an incomplete abortion. They require a follow-up surgical abortion. About 0.1 to 0.2% of the women experience excessive bleeding and require a blood transfusion.

    Four women of the 2,100 who took part in the initial trials lost sufficient blood to require a transfusion.

    It is not a simple procedure; it has unpleasant side effects. But many women find it more acceptable than an a conventional early-pregnancy elective abortion which involves surgical intervention and perhaps a one day recovery period. In mid-1998-JUL, the Population Council in New York NY released the results of a survey of 2,121 women who had taken RU-486. Half of the women had previously had a surgical abortion. 77% of those women rated RU-486 "more satisfactory." 90% would prefer the pill if they had another abortion and would recommend it to others. 

    Author S. Boyd cited a report published in the Journal of the American Medical Women's Association. The report listed a number of reasons why many women interviewed from "various races, ethnicities, education levels and socioeconomic backgrounds" preferred RU-486 over a surgical abortion:

    What does the expelled embryo look like?

    Part of the RU-486 induced abortion process is the expelling of the developing embryo from the woman's body. This typically happens at home.

    As expected, pro-lifers and pro-choicers take different views on how upsetting this is to a woman:

    In an ideal situation, the woman will realize that she may be pregnant when the expected start of her period is delayed by a week or so. She might take a home pregnancy test at that time, find that she is pregnant, visit her doctor or clinic, and take the first RU486 pill. This would terminate the pregnancy, about three weeks after conception. The embryo would be about 1/12" long, the size of a pencil point. It most closely resembles a worm -- long and thin and with a segmented end.

    If she delayed the procedure by an extra week, the embryo would have grown to a length of about 1/5", and would resemble a tiny tadpole. The structure that will develop into a head is visible, as is a noticeable tail. The embryo has structures that resemble the gills of a fish in the area that will later develop into a throat.

    If she delayed the procedure by two weeks, the embryo would be about 5 weeks from conception. That is approaching the limit beyond which RU-486 is not usually taken. Tiny arm and leg buds have formed. Hands with webs between the fingers have formed at the end of the arm buds. The face "has a distinctly reptilian aspect." 

    Another week later, about 6 weeks from conception, It is typically about 1/2" long. The face has two eyes on the side of its head; the front of the face has "connected slits where the mouth and nose eventually will be." 

    At 7 weeks, the embryo has almost lost its tail. "The face is mammalian but somewhat pig-like." 6 That is the time limit beyond which RU486 is not generally used. A surgical abortion would normally be indicated at this stage of gestation.

    The medication "mifepristone" was developed in France by Dr. Etienne-Emile Baulieu in 1980. He found a method of preventing a woman's body from producing a hormone that sustains early pregnancy. The pill is widely know as "RU-486" throughout North America. The letters is taken from the initials of the pharmaceutical company Roussel-Uclaf. The "486" is an arbitrary lab serial number. 1 It was first introduced in France, where it is called Mifegyne®. It has been used, in combination with prostaglandin medication, to induce abortions in about 500,000 women over the last two decades.

    Over the last fifteen years, dozens of clinical studies on RU-486 have been conducted with thousands of women in over 20 countries, including France, Britain, Spain, Germany, the Netherlands, Switzerland, the U.S., Scandinavia, and the former Soviet Union. 2 By 1999, mifespristone was approved for marketing and sale in Austria, Belgium, Denmark, Finland, Germany, Greece, Israel, the Netherlands and Spain. 3 Danco Laboratories, the U.S. distributor had expected to be selling the pill in that country by the end of 1999. 2 That did not happen. The FDA finally approved the pill for U.S. distribution on 2000-SEP-28. It first became available in 2000-DEC. The Alan Guttmacher Institute estimates that during the first six months of 2001, more than 37,000 abortions were induced using RU-486 and similar medication. This represented approximately six percent of all abortions performed. 4

    As of 2002-MAY, initial indications are that about 29% of women who are eligible to use RU-486, and to whom it was offered, have chosen it in preference to a surgical abortion. 5

    A-Woman.com

    Search for old stuff: